The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...
Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday ...
Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...
Ben Foster has revealed the brutally honest chat he had with Phil Parkinson before sensationally joining Wrexham for a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback